Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

Similar articles for PubMed (Select 21382914)

1.

Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide.

López-Lázaro M, Calderón-Montaño JM, Burgos-Morón E, Austin CA.

Mutagenesis. 2011 Jul;26(4):489-98. doi: 10.1093/mutage/ger006. Epub 2011 Mar 7.

3.

The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.

López-Lázaro M, Willmore E, Austin CA.

Mutat Res. 2010 Feb;696(1):41-7. doi: 10.1016/j.mrgentox.2009.12.010. Epub 2009 Dec 16.

PMID:
20025993
4.

Selenite induces topoisomerase I and II-DNA complexes in K562 leukemia cells.

López-Lázaro M, Willmore E, Elliott SL, Austin CA.

Int J Cancer. 2008 Nov 1;123(9):2217-21. doi: 10.1002/ijc.23783.

PMID:
18712718
5.

Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects.

Yamamoto T, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, Ueta E, Osaki T, Athar M, Schuster G, Hsu S.

J Pharmacol Exp Ther. 2004 Jan;308(1):317-23. Epub 2003 Oct 20.

6.

Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.

Calderón-Montaño JM, Burgos-Morón E, Orta ML, Pastor N, Perez-Guerrero C, Austin CA, Mateos S, López-Lázaro M.

Pharmacol Rep. 2012;64(6):1515-25.

7.
8.

Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II.

Suzuki K, Yahara S, Hashimoto F, Uyeda M.

Biol Pharm Bull. 2001 Sep;24(9):1088-90.

9.

(-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases.

Bandele OJ, Osheroff N.

Chem Res Toxicol. 2008 Apr;21(4):936-43. doi: 10.1021/tx700434v. Epub 2008 Feb 23.

10.

Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.

López-Lázaro M, Willmore E, Jobson A, Gilroy KL, Curtis H, Padget K, Austin CA.

J Nat Prod. 2007 Dec;70(12):1884-8. Epub 2007 Dec 13.

PMID:
18076140
11.

Cells lacking DNA topoisomerase II beta are resistant to genistein.

López-Lazaro M, Willmore E, Austin CA.

J Nat Prod. 2007 May;70(5):763-7. Epub 2007 Apr 6.

PMID:
17411092
12.

Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate.

Nakagawa H, Hasumi K, Woo JT, Nagai K, Wachi M.

Carcinogenesis. 2004 Sep;25(9):1567-74. Epub 2004 Apr 16.

13.

Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line.

Suh KS, Chon S, Oh S, Kim SW, Kim JW, Kim YS, Woo JT.

Cell Biol Toxicol. 2010 Jun;26(3):189-99. doi: 10.1007/s10565-009-9137-7. Epub 2009 Sep 12.

PMID:
19757103
14.

In vitro cytotoxicity of (-)-catechin gallate, a minor polyphenol in green tea.

Babich H, Zuckerbraun HL, Weinerman SM.

Toxicol Lett. 2007 Jul 10;171(3):171-80. Epub 2007 May 31.

PMID:
17606338
15.

Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol.

Roy M, Chakrabarty S, Sinha D, Bhattacharya RK, Siddiqi M.

Mutat Res. 2003 Feb-Mar;523-524:33-41.

PMID:
12628501
16.

Effect of yerba mate (Ilex paraguariensis) tea on topoisomerase inhibition and oral carcinoma cell proliferation.

Gonzalez de Mejia E, Song YS, Ramirez-Mares MV, Kobayashi H.

J Agric Food Chem. 2005 Mar 23;53(6):1966-73.

PMID:
15769122
17.
18.

Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants.

Sakagami H, Arakawa H, Maeda M, Satoh K, Kadofuku T, Fukuchi K, Gomi K.

Anticancer Res. 2001 Jul-Aug;21(4A):2633-41.

PMID:
11724332
19.

Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.

Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H.

Biochem Biophys Res Commun. 2001 Oct 19;288(1):101-5.

PMID:
11594758
20.

Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.

Salerno S, Da Settimo F, Taliani S, Simorini F, La Motta C, Fornaciari G, Marini AM.

Curr Med Chem. 2010;17(35):4270-90. Review.

PMID:
20939813
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk